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Abstract: Large scale grids for in silico drug discovery open opportunities of 
particular interest to neglected and emerging diseases. In 2005 and 2006, we 
have been able to deploy large scale virtual docking within the framework of 
the WISDOM initiative against malaria and avian influenza requiring about 100 
years of CPU on the EGEE, Auvergrid and TWGrid infrastructures. These 
achievements demonstrated the relevance of large scale grids for the virtual 
screening by molecular docking. This also allowed evaluating the performances 
of the grid infrastructures and to identify specific issues raised by large scale 
deployment. 
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1 Introduction 
In silico drug discovery is one of the most promising strategies to speed-up the drug 
development process [1]. Virtual screening is about selecting in silico the best 
candidate drugs acting on a given target protein [2]. Screening can be done in vitro 
but it is very expensive as there are now millions of chemicals that can be synthesized 
[3]. A reliable way of in silico screening could reduce the number of molecules 
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required for in vitro and then in vivo testing from a few millions to a few hundreds. 
 In silico drug discovery should foster collaboration between public and private 
laboratories. It should also have an important societal impact by lowering the barrier 
to develop new drugs for rare and neglected diseases [4]. New drugs are needed for 
neglected diseases like malaria where parasites keep developing resistance to existing 
drugs or sleeping sickness for which no new drug has been developed for years. New 
drugs against tuberculosis are also needed as the treatment now takes several months 
and is therefore hard to manage in developing countries. 
 However, in silico virtual screening requires intensive computing, in the order of a 
few TFlops per day to compute 1 million docking probabilities or for the molecular 
modelling of 1,000 compounds on one target protein. Access to very large computing 
resources is therefore needed for successful high throughput virtual screening [5]. 
Grids now provide such resources. A grid infrastructure such as EGEE [6] today 
provides access to more than 30,000 computers and is particularly suited to compute 
docking probabilities for millions of compounds. Docking is only the first step of 
virtual screening since the docking output data has to be processed further [7]. 
 After introducing the case for large scale in silico docking on grids, this paper will 
present the context and objectives of the two initiatives against malaria and avian 
influenza in chapters 2 and 3. In chapter 4, the grid infrastructures and the 
environments used for large scale deployment are briefly described. Results and 
performance of grid environment are discussed in chapter 5. In chapter 6, we will 
also suggest some perspectives for the coming years. 
2 Large Scale In Silico Docking against Malaria 
2.1 Introduction 
The number of cases and deaths from malaria increases in many parts of the world. 
There are about 300 to 500 million new infections, 1 to 3 million new deaths and a 1 
to 4% loss of gross domestic product (at least $12 billion) annually in Africa caused 
by malaria. The main causes for the comeback of malaria are that the most widely 
used drug against malaria, chloroquine, has been rendered useless by drug resistance 
in much of the world [8,9] and that anopheles mosquitoes, the disease carrier, have 
become resistant to some of the insecticides used to control the mosquito population.  
 Genomics research has opened up new ways of finding novel drugs to cure 
malaria, vaccines to prevent malaria, insecticides to kill infectious mosquitoes and 
strategies to prevent development of infectious sporozoites in the mosquito [10]. 
These studies require more and more in silico biology; from the first steps of gene 
annotation via target identification to the modeling of pathways and the identification 
of proteins mediating the pathogenic potential of the parasite. Grid computing 
supports all of these steps and, moreover, can also contribute significantly to the 
monitoring of ground studies to control malaria and to the clinical tests in plagued 
areas.   
 A particularly computing intensive step in the drug discovery process is virtual 
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screening which is about selecting in silico the best candidate drugs acting on a given 
target protein. Screening can be done in vitro using real chemical compounds, but this 
is a very expensive not necessarily error-free undertaking. If it could be done in silico 
in a reliable way, one could reduce the number of molecules requiring in vitro and 
then in vivo testing from a few millions to a few hundreds [11]. Advance in 
combinatorial chemistry has paved the way for synthesizing millions of different 
chemical compounds. Thus there are millions of chemical compounds available in 
pharmaceutical laboratories and also in a very limited number of publicly accessible 
databases. 
 The WISDOM experiment ran on the EGEE grid production service during 
summer 2005 to analyze one million drug candidates against plasmepsin, the aspartic 
protease of plasmodium responsible for the initial cleavage of human haemoglobin. 
2.2 Objectives 
Grid Objective 
A large number of applications are already running on grid infrastructures. Even if 
many have passed the proof of concept level [12], only few are ready for large-scale 
production with experimental data. Large Hadron Collider experiments at CERN, like 
the ATLAS collaboration [13], have been the first to test a large data production 
system on grid infrastructures [14]. In a similar way, WISDOM [15] aimed at 
deploying a scalable, CPU consuming application generating large data flows to test 
the grid infrastructure, operation and services in very stressing conditions. 
 Docking is – along with BLAST [16] homology searches and some folding 
algorithms – one of the most prominent applications that have successfully been 
demonstrated on grid testbeds [17,18]. It is typically an embarrassingly parallel 
application, with repetitive and independent calculations. Large resources are needed 
in order to test a family of targets, a significant amount of possible drug candidates 
and different virtual screening tools with different parameter/scoring settings. This is 
both a computational and data challenge problem to distribute millions of docking 
comparisons with millions of small compound files.  
 Moreover, docking is the only application for distributed computing that has 
prompted the uptake of grid technology in the pharmaceutical industry [19]. The 
WISDOM scientific results are also a means of making a demonstration of the EGEE 
grid computing infrastructure for the end users community, of illustrating the 
usefulness of a scientifically targeted Virtual Organization, and of fostering an uptake 
of grid technologies in this scientific area [20]. 
Biological Objective 
Malaria is a dreadful disease caused by a protozoan parasite, plasmodium. A new 
strategy to fight malaria investigated within WISDOM aims at the haemoglobin 
metabolism, which is one of the key metabolic processes for the survival of the 
parasite. Plasmepsin, the aspartic protease of plasmodium, is responsible for the initial 
cleavage of human haemoglobin and later followed by other proteases [21]. There are 
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ten different plasmepsins coded by ten different genes in Plasmodium falciparum [8]. 
High levels of sequence homology are observed between different plasmepsins (65-
70%). Simultaneously they share only 35% sequence homology with its nearest 
human aspartic protease, Cathepsin D4 [9]. This and the presence of accurate X 
crystallographic data make plasmepsin an ideal target for rational drug design against 
malaria. 
 Docking is a first step for in silico virtual screening. Basically, protein-compound 
docking is about estimating the binding energy of a protein target to a library of 
potential drugs using a scoring algorithm. The target is typically a protein, which 
plays a pivotal role in a pathological process, e.g. the biological cycles of a given 
pathogen (parasite, virus, bacteria…). The goal is to identify which molecules could 
dock on the protein’s active sites in order to inhibit its action and therefore interfere 
with the molecular processes essential for the pathogen. Libraries of compound 3D 
structures are made openly available by chemistry companies, which can produce 
them. Many docking software products are available either open-source or through a 
proprietary license. 
3 In silico Docking against Avian Influenza 
3.1 Introduction 
The first large scale docking experiment focused on virtual screening for neglected 
diseases but new perspectives appear also for using grids to address emerging 
diseases. While the grid added value for neglected diseases is related to their cost 
effectiveness as compared to in vitro testing, grids are also extremely relevant when 
time becomes a critical factor. A collaboration between Asian and European 
laboratories has analyzed 300,000 possible drug compounds against the avian 
influenza virus H5N1 using the EGEE grid infrastructure in April and May 2006 [22]. 
The goal was to find potential compounds that can inhibit the activities of an enzyme 
on the surface of the influenza virus, the so-called neuraminidase, subtype N1. Using 
the grid to identify the most promising leads for biological tests could speed up the 
development process for drugs against the influenza virus. 
3.2 Objectives 
Grid Objective 
Beside the biological goal of reducing time and cost of the initial investment on 
structure-based drug design, there are two grid technology objectives for this activity: 
one is to improve the performance of the in silico high-throughput screening 
environment based on what has been learnt in the previous challenge against malaria; 
the other is to test another environment which enables users to control the massive 
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molecular dockings on the grid. Therefore, two Grid tools were used in parallel in this 
second large scale deployment. An enhanced version of WISDOM high-throughput 
workflow was designed to achieve the first goal and a lightweight framework called 
DIANE [23,24] was introduced to carry a significant fraction of the deployment for 
implementing and testing the new scenario. 
Biological Objective 
The potential for reemergence of influenza pandemics has been a great threat since 
the report that avian influenza A virus (H5N1) could acquire the ability to be 
transmitted to humans. Indeed, an increase of transmission incidents suggests a risk of 
human-to-human transmission [25]. In addition, the report of the development of drug 
resistant variants [26] is of potential concern. Two of the present drugs (oseltamivir 
and zanamivir) were discovered through structure-based drug design targeting 
influenza neuraminidase (NA), a viral enzyme that cleaves terminal sialic acid 
residues from glycoconjugates. The action of NA is essential for virus proliferation 
and infectivity; therefore, blocking its activity generates antivirus effects. To 
minimize non-productive trial-and-error approaches and to accelerate the discovery of 
novel potent inhibitors, medical chemists take advantage of modelled NA variant 
structures and structure-based design. 
 To achieve this goal, molecular docking engines, such as AutoDock [27], carry 
out a quick conformational search for small compounds in the binding sites, fast 
calculation of binding energies of possible binding poses, prompt selection for the 
probable binding modes, and precise ranking and filtering for good binders. Although 
docking engines can be run automatically, one should control the dynamic 
conformation of the macromolecular binding site (rigid or flexible) and the spectrum 
of the screening small organics. This process is characterized by computational and 
storage loads which pose a great challenge to resources that a single institute can 
afford. 
4 The Grid Tools 
4.1 The Grid Infrastructures 
Compared to WISDOM which used only the EGEE infrastructure, the large scale 
deployment against avian influenza used three infrastructures which are sharing the 
same middleware (LCG2) and also common services: Auvergrid, EGEE and TWGrid.  
Auvergrid is regional grid deployed in the French region Auvergne. Its goal is to 
explore how a grid can provide the resources needed for public and private research at 
a regional level. With more than 800 CPUs available at 12 sites, Auvergrid hosts a 
variety of scientific applications from particle physics to life science, environment 
and chemistry. 
TWGrid is responsible for operating a Grid Operation Centre in Asia-Pacific region. 
Apart from supporting the worldwide grid collaboration in high-energy physics, 
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TWGrid is also in charge of federating and coordinating regional grid resources to 
promote the grid technology to the e-Science activities (e.g. life science, atmospheric 
science, digital archive, etc.) in Asia. 
The EGEE project [6] (Enabling Grid for E-sciencE) brings together experts from 
over 27 countries with the common aim of building on recent advances in grid 
technology and developing a service grid infrastructure which is available to scientists 
24 hours a day. The project aims to provide researchers in academia and industry with 
access to major computing resources, independent of their geographic location. The 
EGEE infrastructure is now a production grid with a large number of applications 
installed and used on the available resources. The infrastructure involves more than 
180 sites spread out across Europe, America and Asia. 
 The two applications described in this paper were deployed within the framework 
of the biomedical Virtual Organization. Resource nodes available for biomedical 
applications scale up to 3,000 CPUs and 21 TB disk space. The resources are spread 
over 15 countries. 
4.2 The WISDOM Production Environment 
 A large-scale deployment requires the development of an environment for 
job submission and output data collection. The EGEE Workload Management System 
[6] is responsible for the management and monitoring of jobs. The Job Description 
Language is used to describe the jobs and their requirements like targeted 
workstations. A set of services running on the Resource Broker machine matches job 
requirements expressed in the Job Description Language files to the available 
resources (as gathered from the Information System), distributes the jobs over the 
matching Computing Elements, tracks the job status, and allows users to retrieve their 
job output. Computing Elements are frontals to computing centre clusters. They plan 
jobs execution over the available Worker Nodes through batch schedulers. 
 A number of issues need to be addressed to achieve significant acceleration from 
the grid deployment: 
- Grid performances are impacted by the amount of data moved around at job 
submission. Consequently, the files providing the 3D structure of targets and 
compounds should preferably be stored on grid storage elements in preparation for 
the data challenge. 
- The rate at which jobs are submitted to the grid resource brokers must be carefully 
monitored in order to avoid their overload. The job submission scheme must take 
into account this present limitation of the EGEE brokering system. 
- Grid submission process introduces significant delays for instance at the level of 
resource brokering. The jobs submitted to the grid computing nodes must be 
sufficiently long in order to reduce the impact of this middleware overhead.  
 The WISDOM production environment [28] was designed to achieve production 
of a large amount of data in a limited time using EGEE, Auvergrid and TWGrid 
middleware services. Three packages were developed in Perl and Java. Their entry 
points are a simple command line tool. The first package installs the application 
components (software, compounds database…) on the grid computing nodes. The 
second package tests these components. The third package monitors the submission 
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and the execution of the WISDOM jobs. Figure 1 illustrates the packages and the 
steps of the jobs execution. 
 
BIOMEDICAL VO
LCG components
EGEE resources
Application components
wisdom_install
Installer Tester
wisdom_test
wisdom_execution
Workload definition
Job submission
Job monitoring
Job bookkeeping
Fault tracking
Fault fixing
Job resubmission
Instance
User
wisdom_collect
Accounting data
Superviser
wisdom_sitewisdom_db
License server
 
Fig. 1. Design of the WISDOM production system 
 The environment was improved to address limitations and bottlenecks identified 
during the first data challenge against Malaria deployed in the summer of 2005 on the 
EGEE infrastructure. 
- The number of resource broker machines and the rate at which the jobs were 
submitted to these grid services were reduced to avoid their overload. 
- Another improvement concerned the resubmission process after a job failure, 
which was redesigned to avoid “sinkhole” effect on a failing grid-computing node. 
Automatic resubmission was replaced by the manual intervention of the WISDOM 
production user. 
- Mis-configuration of the grid sites was an important cause of failure (see table 1). 
In the first data challenge, the compound database was installed on each Storage 
Element of the grid, and the docking binary was installed on each Software 
Repository of the grid Computing Elements. The Software Repository is dedicated 
to a Virtual Organization for installing binaries on each grid site. But many jobs 
failed to access database and software because of site mis-configuration appearing 
during the deployment. In the data challenge against avian influenza, all the input 
data were stored on only three Storage Elements. Advantages are the simpler 
management of only three grid sites and the use of basic transfer commands 
instead of more complex software repository commands. 
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4.3 The DIANE Framework 
DIANE (Distributed Analysis Environment, http://cern.ch/diane/) is a lightweight 
distributed framework for parallel scientific applications in master-worker model 
[23,24]. It assumes that a job may be split into a number of independent tasks, which 
is a typical case in many scientific applications. It has been successfully applied in a 
number of applications ranging from image rendering to data analysis in high-energy 
physics. 
 As opposed to standard message passing libraries such as MPI [29], the DIANE 
framework takes care of all synchronization, communication and workflow 
management details on behalf of the application. The execution of a job is fully 
controlled by the framework, which decides when and where the tasks are executed. 
Thus the application is very simple to program and contains only the essential code 
directly related to the application itself without bothering about networking details. 
Aiming to efficiently bridge underlying distributed computing environments and 
application centric user interface, DIANE itself is a thin software layer which can 
easily work on top of more fundamental middleware such as LSF, PBS or the grid 
Resource Brokers. It may also work in a standalone mode and does not require any 
complex underlying software. 
 
+__init__()
+env_createPlan()
Planner
+__init__()
+env_init()
+env_addPartialOutput()
Integrator
+__init__()
+env_init()
+env_performWork()
Worker
The DIANE task queue
based on the execution plan
Request new task Return task result
Generate task queue
DIANE Master
DIANE Worker
 
Fig. 2. Template of DIANE application plug-ins 
As a framework, DIANE provides an adapter for applications. Figure 2 shows the 
template of DIANE application plug-ins. A complete DIANE application plug-in 
should implement three major Python objects: the Planner and the Integrator objects 
implement the job splitting and result merging, respectively; while the logic of the 
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Worker object concentrates on the execution of the individual task. When a DIANE 
job is started by a user, both the Planner and the Integrator objects are invoked by a 
master agent usually executed on the user's desktop, and typically the worker agents 
are submitted to run on distributed CPUs such as the grid Worker Nodes. 
 Once the worker agent is launched, it first registers itself with the master agent. In 
the second step, a channel is established for pulling the tasks from the queue held by 
the master agent. When the worker agent has finished the individual task, the result is 
returned and merged on the master. The pulling-executing-returning cycle will iterate 
until all the tasks are accomplished. The same channel is also used to profile the 
worker agent's health and to support user interaction with the task. The whole DIANE 
framework is written in Python and the communication between the master agent and 
the worker agents is based on the CORBA protocol. 
Further details on DIANE can be found in [23] and [24].  
5 Results 
5.1 WISDOM Results 
The WISDOM experiment ran on the EGEE grid production service from 11 July 
2005 until 19 August 2005. It saw over 42 million docked compounds, the equivalent 
of 80 years on a single PC, in about 6 weeks. FlexX [30], a commercial docking 
software with a license server, was successfully deployed during three weeks on more 
than 1,000 machines at the same time. Then Autodock, a free for academic docking 
software, was deployed during three weeks and used up to 1,700 computers in 15 
countries around the world. WISDOM demonstrated how grid computing can help 
drug discovery research by speeding up the whole process and reduce the cost to 
develop new drugs to treat diseases such as malaria. The analysis of the performance 
and the cause of failures are detailed in [28] and summarized below. 
Grid Performances 
The large scale deployment was a very useful experience to identify the limitations 
and bottlenecks of the EGEE infrastructure. 
 The success rate formula used for measuring EGEE Quality of Service stands as 
follows:  
 
 Successful jobs / (submitted jobs – cancelled jobs) 
 
 where successful jobs are jobs which have been executed successfully, submitted 
jobs are the jobs launched by the user from the User Interface, cancelled jobs are jobs 
cancelled by the user. The proposed definition of the success rate is not completely 
relevant from a user point of view as a successful job as seen from the grid can be 
unsuccessful from a user perspective if it did not produce the expected output data. As 
a consequence, our definition of the success rate during these experiments took into 
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account the quality of the data produced. Successful jobs were defined as jobs 
executed successfully on the grid which produced the expected data. The content of 
the output data file was checked through an automatic procedure. All sources of 
failures were registered during the 6 weeks; the failure rate was defined as the ratio of 
failures of a given origin to the total number of jobs submitted minus the number of 
jobs cancelled. We also introduced the concept of grid success rate defined as the 
success rate after checking output data and subtracting WISDOM and server license 
failures. All the unsuccessful tasks are resubmitted and recomputed by the WISDOM 
production environment. 
 The success rate after checking output data was 46% while the grid success rate 
was of the order of 63%. This means that a large fraction of the jobs had to be 
resubmitted. This generated a significantly larger workload for the users. The 
different sources of failures are identified on table 1 with their corresponding rates.  
Table 1. Origin of failures during the WISDOM deployment with their corresponding rates 
 Rate Reasons 
Success rate after checking output data 46 %  
Workload Management failure 10 % Overload, disk failure 
Misconfiguration, disk space problem 
Air-conditioning, power cut 
Data Management failure 4 % Network / connection 
Power cut 
Other unknown causes 
Sites failure 9 % Misconfiguration, tar command, disk space 
Information system update 
Job number limitation in the waiting queue 
Air-conditioning, power cut 
Unclassified 4 % Lost jobs 
Other unknown causes 
Server license failure 23 % Server failure 
Power cut 
Server stop 
WISDOM failure 4 % Job distribution 
Human error 
Script failure 
 
 Two docking tools were used on the grid during WISDOM deployment, namely 
Autodock and FlexX. In the phase where proprietary licensed software FlexX was 
deployed on the grid, the dominant origin of failure was the license server in charge 
of distributing tokens to all the jobs running on the grid. Each job using FlexX 
software was contacting the Flexlm server at the beginning of the job, asked for a 
license and then was able to run without connection to the license server. When the 
server is down (for example by a power cut), the jobs can not connect to the server 
and are considered to have failed. The development of a grid service to manage 
proprietary licensed software is under way to address this single point of failure 
ignored by the information system.  
 The second most important sources of failure were workload management and site 
failures, including overload, disk failure, node mis-configuration, disk space problem, 
Virtual Screening on Large Scale Grids      11 
air-conditioning and power cut. To improve the job submission process, an automatic 
resubmission of jobs was included in the WISDOM execution environment. However, 
the consequence of automatic resubmission was the creation of several “sinkhole” 
effects where all the jobs were attracted to a single node. These sinkhole effects were 
observed when the status of a Computing Element was not correctly described in the 
information system. If a Computing Element already loaded is still viewed as 
completely free by the Information System, it keeps receiving jobs from the Resource 
Broker. If the Computing Element gets down, all jobs are aborted. Even if the 
Computing Element can support the excessive number of jobs, the processing time is 
going to be very long. 
 The WISDOM production system developed to submit the jobs on the grid 
accounted for a small fraction of the failures, as did also the grid data management 
system. About 1 terabyte of data was produced by the 72,000 jobs submitted. 
Collection and registration of these output data turned out to be a heavy task. The grid 
data management services allowed replicating all the output files for backup. 
However, they did not allow storing all the results directly in a database to ease the 
final analysis by the end-user. WISDOM experience was the opportunity to learn 
from biochemists the relevant parameters to extract from the docking output file so 
that the next implementation of the production environment will offer this service to 
the end-users.  
Finally, unclassified failures accounted for 4% of inefficiency. This illustrates the 
work which is still needed to improve grid monitoring. 
 In terms of grid throughput, the resource brokers significantly limited the rate at 
which the jobs could be submitted. Another significant source of inefficiency came 
from the difficulty for the grid information system to provide all the relevant 
information to the resource brokers when they distribute the jobs on the grid. 
Therefore, job scheduling was a time-consuming task for the WISDOM users during 
all the data challenge due to the encountered limitations of the information system, 
the computing elements and the resource brokers. The achieved throughput averaged 
about 12 docked compounds per second during the whole computing challenge.  
 Several of the issues identified during WISDOM deployment were improved for 
the second large scale docking targeted on avian influenza which is described in the 
next chapter. 
WISDOM Biological Results 
Post-processing of the huge amount of data generated was a very demanding task as 
millions of docking scores had to be compared. At the end of the large scale docking 
deployment, the best 1,000 compounds based on scoring were selected thanks to post-
processing ranking jobs deployed on the grid. They were inspected individually. 
Several strategies were employed to reduce the number of false positives. A further 
100 compounds were selected for post-processing. These compounds had been 
selected based on the docking score, the binding mode of the compound inside the 
binding pocket and the interactions of the compounds to key residues of the protein.  
 There are several scaffolds in the 100 compounds selected for post processing. 
The scaffolds urea, thiourea, and guanidino analogues are most repeatedly identified 
in the top 1,000 compounds. Some of the compounds identified were similar to 
already known plasmepsin inhibitors, like the urea analogues which were already 
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established as micro molar inhibitors for plasmepsins (Walter Reed compounds) [31]. 
This indicates that the overall approach is sensible and that large scale docking on 
computational grids has potential to identify new inhibitors. The guanidino analogues 
can become a novel class of plasmepsin inhibitors.  
5.2 Results from the Large Scale Deployment against Avian Influenza 
Table 2 summarizes the achieved deployments using WISDOM and DIANE 
environments. The crunching factor represents the gain of time obtained thank to the 
grid deployment. It is simply obtained by dividing the total CPU time by the 
execution duration. The approximated distribution efficiency is defined as the ratio 
between the crunching factor and the maximum number of concurrently running 
CPUs. 
Table 2. Statistical summary of the WISDOM and DIANE activities 
 WISDOM DIANE 
Total number of completed dockings 2 * 106 308,585 
Estimated duration on 1 CPU 88.3 years 16.7 years 
Duration of the experience 6 weeks 4 weeks 
Cumulative number of grid jobs 54,000 2,585 
Maximum number of concurrent CPUs 2,000 240 
Number of used Computing Elements 60 36 
Crunching factor 912 203 
Approximated distribution efficiency 46% 84% 
  
 The WISDOM production environment was used to distribute 54,000 jobs on 60 
grid Computing Elements to dock about 2 million pairs of target and chemical 
compound for a total amount of about 88 CPU years. Because the grid resources were 
used by other Virtual Organizations during the deployment, a maximum of 2,000 
CPUs were concurrently running at the same time. For the DIANE part, we were able 
to complete 308,585 docking runs (i.e. 1/8 of the whole deployment) in 30 days using 
the computing resources of 36 grid nodes. A total number of 2,585 DIANE worker 
agents have been running as grid jobs during that period and the DIANE master 
concurrently maintained 240 of them. The distribution of those grid jobs in terms of 
the regions of the world is shown on Figure 3. About 600 gigabytes of data has been 
produced on the grid during the deployment. 
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EGEE Russia 4%
EGEE Germany-
Switzerland 2%EGEE Central Europe 2%
EGEE Northern Europe 
4%
EGEE Italy 6%
EGEE SouthEastern 
Europe 14%
EGEE SouthWestern 
Europe 15%
EGEE France 19%
AuverGrid 7%
TWGrid 4%
EGEE UK 23%
 
Fig. 3. Distribution of the grid jobs in different region. 
Grid Performances 
Since a grid is a dynamic system in which the status of resources may change without 
central control, transient problems occur which cause job failures. In the WISDOM 
activity, the success rate after checking output data is 70% and the grid success rate is 
80%; the observed failures were mainly due to errors at job scheduling time because 
of misconfiguration of grid Computing Elements and frequent last-minute errors in 
the transfer of results to the grid Storage Elements. Compared to the previous large 
scale deployment, improvement is significant as the observed success rates were 
respectively 46 and 63%. The last-minute error in output data transfer is particularly 
expensive since the results are no longer available on the grid Worker Node although 
they might have been successfully produced. 
 In DIANE, similar job failure rates were also observed; nevertheless, the failure 
recovery mechanism in DIANE automated the re-submission and guaranteed a finally 
fully complete job. On the other hand, the feature of interactively returning part of the 
computing efforts during the runtime (e.g. the output of each docking) also introduces 
a more economical way of using the grid resources.  
 For the instances submitted using WISDOM production environment, the overall 
crunching factor was about 912. The corresponding distribution efficiency was 
estimated to 46%. This is due to the known issue of long job waiting time in the 
current EGEE production system.  
 The task pull model adopted by DIANE allows isolating the scheduling overhead 
of the grid jobs and is therefore expected to achieve a better distribution efficiency. 
During the deployment, DIANE was able to push the efficiency to higher than 80% 
within the scope of handling intermediate scale of distributed docking. A fare 
comparison with WISDOM can only be made if the improvement of the DIANE 
framework is tested in a large scale as the exercise of WISDOM. 
Biological Results 
Two sets of re-ranked data for each target were made (QM-MM method and selection 
by the study of the interactions between the compound and the target active site). The 
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top 15% is about 45,000 compounds for each target. This set will be publicly 
available for the scientific community working on the avian influenza neuraminidase. 
The top 5% is about 2,250 compounds for each target. This set will be refined by 
different methods (molecular modeling, molecular dynamics…). The analysis will 
indicate which residue mutation is critical, which chemical fragments are preferred in 
the mutation sub sites and other information for lead optimization to chemists. 
Finally, at least 25 compounds will be assayed experimentally at the Genomic 
Research Center from Academia Sinica. 
6 Perspectives 
The results obtained by the first two high throughput virtual docking deployments 
have opened important perspectives. On the grid side, developments are under way to 
further improve the WISDOM and DIANE environments to improve the quality of 
service offered to the end-users. From an application point of view, beyond the 
necessity to analyze the results obtained on malaria and avian influenza, it is 
particularly relevant to further enable the deployment of virtual screening on large 
scale grids.  
6.1 Perspective on the Grid Side: WISDOM-II 
The impact of the first WISDOM deployment has significantly raised the interest of 
the research community on neglected diseases so that several laboratories all around 
the world have expressed interest to propose targets for a second large scale 
deployment called WISDOM-II. Contacts have been established with research groups 
from Italy, United Kingdom, Venezuela, South Africa and Thailand and discussions 
are under way to finalize the list of targets to be docked. 
 Similarly, several grid projects have expressed interest to contribute to the 
WISDOM initiative by providing computing resources (Auvergrid, EELA 
(http://www.eu-eela.org/), South East Asia Grid, Swiss Biogrid 
(http://www.swissbiogrid.com/)) or by contributing to the development of the virtual 
screening pipeline (Embrace (http://www.embracegrid.info/), BioinfoGRID 
(http://www.bioinfogrid.eu/)). 
6.2 From Virtual Docking to Virtual Screening 
While docking methods have been significantly improved in the last years by 
including more through compound orientation search, additional energy contributions 
and/or refined parameters in the force field, it is generally agreed that docking results 
need to be post-processed with more accurate modeling tools before biological tests 
are undertaken. Molecular dynamics (MD) [32] has great potential at this stage: 
firstly, it enables a flexible treatment of the compound/target complexes at room 
temperature for a given simulation time, and therefore is able to refine compound 
orientations by finding more stable complexes; secondly, it partially solves 
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conformation and orientation search deficiencies which might arise from docking; 
thirdly, it allows the re-ranking of molecules based on more accurate scoring 
functions.  
 Figure 4 illustrates how the best hits coming out the docking step need to be 
further processed and analyzed with MD. 
 However, for the same number of compounds, MD analysis requires much heavier 
computing than docking. Consequently, MD can only be applied to a restricted 
number of compounds, usually the best hits coming out of the docking step. MD and 
subsequent free-energy analysis most often changes significantly the scoring of the 
best compounds and it is therefore very important to apply it to as many compounds 
as possible. As a consequence, grids appear very promising to improve the virtual 
screening process by increasing the number of compounds that will be processed 
using MD. 
For instance, running MD analysis with Amber 8 [33] software on one protein 
target and 10,000 compounds requires about 50 CPU years for a model with a few 
thousands atoms and a few tens of thousands of steps. This process produces only tens 
gigabytes of data. One run with only one compound takes 44 hours (computing time 
heavily depends on choice of conditions, like explicit water simulations, or 
generalized born simulations). 
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Fig. 4. First steps of the in silico drug discovery pipeline on the grid 
 Deployment of MD computing is relevant on grids of clusters such as EGEE and 
grids of supercomputers such as DEISA (http://www.deisa.org/), which is an 
European Supercomputing Service built on top of existing national services and based 
on the deployment and operation of a persistent, production quality, distributed 
supercomputing environment with continental scope. MD computations of large 
molecules are significantly faster on a supercomputer.  
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 Within the framework of the BioinfoGRID European project which aims to 
expand the grid awareness inside the bioinformatics community, focus will be put on 
the reranking of the best scoring compounds coming out of WISDOM. The goal will 
be to deploy on at least one of the European grid infrastructures MD software to 
rerank the best compounds before in vitro testing.  
7 Conclusion  
Large scale grids offer unprecedented perspectives for in silico drug discovery. This 
paper has presented pioneering activities in the field of grid enabled virtual screening 
against neglected and emerging diseases in Europe. This activity started with a large 
scale docking deployment against malaria on the EGEE infrastructure in 2005, which 
was followed by another large scale deployment focused on avian influenza in the 
spring of 2006. A second large scale deployment on neglected diseases is foreseen to 
take place in the fall: it will involve several European projects, which will bring 
additional resources and complementary contributions in order to enable a complete 
virtual screening process on the grid. 
 These deployments were achieved using two different systems for submission and 
monitoring of virtual docking jobs. The WISDOM system was designed to achieve 
production of a large amount of data in a limited time while the DIANE framework 
was designed as a lightweight distributed framework for parallel scientific 
applications in master-worker model. Both systems were able to provide high 
throughput virtual docking. Development of a new system merging functionalities 
from both WISDOM and DIANE frameworks is under way in the perspective of 
WISDOM-II, second large scale deployment on neglected diseases. 
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